Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-17

Clinical Trial Update: RedStroke - Reducing Europe's Stroke Incidence [NA]

View source ↗

Summary

The RedStroke clinical trial evaluating strategies to reduce stroke incidence in patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Atrial Fibrillation | NA | Status: COMPLETED